Jiang, X-Y <br/><br/>
CYP7A1 polymorphism influences the LDL cholesterol-lowering response to atorvastatin.  [electronic resource] 

 -  Journal of clinical pharmacy and therapeutics  Dec 2012 
 - 719-23 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1365-2710 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2710.2012.01372.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ATP Binding Cassette Transporter, Subfamily G, Member 8<br/>ATP-Binding Cassette Transporters--genetics<br/>Aged<br/>Atorvastatin<br/>China<br/>Cholesterol 7-alpha-Hydroxylase--genetics<br/>Cholesterol, LDL--blood<br/>Cytochrome P-450 CYP3A--genetics<br/>Female<br/>Genetic Variation<br/>Genotype<br/>Heptanoic Acids--pharmacology<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--pharmacology<br/>Hypercholesterolemia--drug therapy<br/>Male<br/>Middle Aged<br/>Polymorphism, Single Nucleotide<br/>Pyrroles--pharmacology